Large cohort study finds no reduction in survival for patients managed with active surveillance compared to treated patients
Research enables precision medicine beyond patients with changed mutational status
Study finds drug safe and effective when combined with chemotherapy
Treatment may be a lifesaving option for patients with relapsed or refractory disease
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Sarcopenia and sarcopenic obesity appear to increase risk of early chemotherapy termination
Study associates human CD38-targeting antibody with fewer complications
Findings suggest that a uniform dose can be an effective preventive strategy
Treatment with GnRH agonists may foster a return to menstruation
New neoadjuvant treatment regimen offers hope to patients facing a poor prognosis
Some supplements associated with negative patient outcomes